214 related articles for article (PubMed ID: 28575250)
1. Characterization of tissue chromogranin A (CgA) immunostaining and clinicohistopathological changes for the 125 Chinese patients with primary small cell carcinoma of the esophagus.
Ku JW; Zhang DY; Song X; Li XM; Zhao XK; Lv S; Hu SJ; Cheng R; Zhou FY; Wu HF; Wang LD
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575250
[TBL] [Abstract][Full Text] [Related]
2. Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases.
Lu J; Xue LY; Lu N; Zou SM; Liu XY; Wen P
Dis Esophagus; 2010 Feb; 23(2):153-9. PubMed ID: 19515193
[TBL] [Abstract][Full Text] [Related]
3. The alterations of cytokeratin and vimentin protein expressions in primary esophageal spindle cell carcinoma.
Li XM; Song X; Zhao XK; Hu SJ; Cheng R; Lv S; Du DF; Zhang XY; Lu JL; Ku JW; Zhang DY; Zhang Y; Fan ZM; Wang LD
BMC Cancer; 2018 Apr; 18(1):356. PubMed ID: 29609569
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram model for Chinese patients with primary small cell carcinoma of the esophagus.
Zhang DY; Huang GR; Ku JW; Zhao XK; Song X; Xu RH; Han WL; Zhou FY; Wang R; Wei MX; Wang LD
World J Clin Cases; 2021 Oct; 9(30):9011-9022. PubMed ID: 34786384
[TBL] [Abstract][Full Text] [Related]
5. [Cox proportional hazard model analysis of prognosis in patients with carcinoma of esophagus and gastric cardia after radical resection].
Liu W; Hao XS; Fan Q; Li HX; Song LN; Wang SJ; Wang PZ; Jin Y; Chen Y; Guan LY; Ping YM; Meng XL; Wang R; Liu JF; Wang XL
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):921-5. PubMed ID: 19173994
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of clinicopathological features of intestinal neuroendocrine neoplasms].
Gao W; Liu SM; Lu HZ; Liang J; Yuan YL; Liu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):450-6. PubMed ID: 22967448
[TBL] [Abstract][Full Text] [Related]
7. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
9. Does tumor size improve the accuracy of prognostic prediction in patients with esophageal squamous cell carcinoma after surgical resection?
Zhang H; Tang P; Miao X; Gao Y; Shang X; Gong L; Ma Z; Yang M; Jiang H; Zhan Z; Meng B; Yu Z
Oncotarget; 2016 Oct; 7(41):66623-66634. PubMed ID: 27579613
[TBL] [Abstract][Full Text] [Related]
10. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
11. Primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical features of 21 cases.
Yun JP; Zhang MF; Hou JH; Tian QH; Fu J; Liang XM; Wu QL; Rong TH
BMC Cancer; 2007 Mar; 7():38. PubMed ID: 17335582
[TBL] [Abstract][Full Text] [Related]
12. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
[TBL] [Abstract][Full Text] [Related]
14. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in node-negative squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Kinugasa S; Dhar DK; Shibakita M; Ohno S; Masunaga R; Kotoh T; Kubota H; Nagasue N
Int J Surg Investig; 2000; 1(5):389-95. PubMed ID: 11341595
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological study of chromogranin A, B and BRCA1 expression in node-negative breast carcinoma.
Yoshida R; Ohuchi N; Kimura N
Oncol Rep; 2002; 9(6):1363-7. PubMed ID: 12375049
[TBL] [Abstract][Full Text] [Related]
17. Clinico-pathological study of esophageal mucoepidermoid carcinoma: a 10-year survival from a single center.
Wang Y; Wu Y; Zheng C; Li Q; Jiao W; Wang J; Xiao L; Pang Q; Zhang W; Wang J
BMC Gastroenterol; 2024 May; 24(1):156. PubMed ID: 38720257
[TBL] [Abstract][Full Text] [Related]
18. Tumor location does not impact long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.
Yang HX; Hou X; Liu QW; Zhang LJ; Liu JG; Lin P; Fu JH
Ann Thorac Surg; 2012 Jun; 93(6):1861-6. PubMed ID: 22551848
[TBL] [Abstract][Full Text] [Related]
19. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
20. [Clinical implications of the new TNM staging system for thoracic esophageal squamous cell carcinoma].
Fang WT; Feng J; Mao T; Fu SJ; Chen WH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):687-91. PubMed ID: 22340051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
